Education
About Us
Working with TipRanks
Follow Us
Myomo Inc (MYO)
:MYO
Earnings Data
Report Date
May 07, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
-0.08Last Year’s EPS
-0.1Same Quarter Last Year
Strong Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Mar 10, 2025
|% Change Since: 32.37%
|Next Earnings Date:May 07, 2025
Earnings Call Sentiment|Positive
The earnings call presented a strong positive sentiment overall, with significant revenue growth, successful expansion into new markets, and improved financial metrics. However, challenges with Medicare Advantage and increased operating expenses are noted as areas of concern.Company Guidance
During the Myomo Fourth Quarter 2024 Earnings Conference Call, CEO Paul Gudonis highlighted the company's significant achievements and outlined guidance for 2025. Myomo reported record revenues of $12.1 million in Q4 and $32.6 million for the full year, marking a 154% increase from the previous year. The company delivered 220 revenue units in Q4 and more than 600 devices throughout the year, with Medicare Part B patients contributing to 57% of Q4 revenue. Myomo's strategic focus includes expanding market access through orthotics and prosthetics (O&P) clinics, which saw a 94% revenue increase in Q4. The company also achieved a gross margin of 71.4% and positive operating cash flow in Q4. Moving forward, Myomo aims to double its advertising budget to over $6 million, hire additional staff, and achieve revenues between $50 million and $53 million in 2025, with an emphasis on second-half growth. The company is also working to increase O&P-driven revenue and expand its international presence, particularly in Germany.Record-Breaking Revenue and Growth
Revenues were $12.1 million for Q4 and $32.6 million for the full year, more than double the quarterly revenue in Q4 '23, and 69% higher revenue than the previous year.
Increased Market Access
Medicare began paying for the MyoPro powered arm brace for medically-qualified patients, allowing access to roughly 50% of the market previously turned away.
Strong Pipeline and Orders
Added 657 medically-qualified candidates to the patient pipeline, ending the year with nearly 1,400 patients in the process of obtaining MyoPro.
Improved Operating Efficiency
Achieved positive adjusted EBITDA for the first time in history, with a significant improvement compared to the previous year.
Successful Capital Raise and Expansion
Completed a successful capital raise to fund growth plans in 2025 and beyond, and increased manufacturing capacity to 120 units per month.
---
MYO Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
MYO Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Mar 10, 2025 | $4.17 | $5.87 | +40.77% |
| Nov 06, 2024 | $4.18 | $5.02 | +20.10% |
| Aug 06, 2024 | $4.20 | $3.64 | -13.33% |
| May 08, 2024 | $3.93 | $3.56 | -9.41% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Myomo Inc (MYO) report earnings?
Myomo Inc (MYO) is schdueled to report earning on May 07, 2025, TBA Not Confirmed.
What is Myomo Inc (MYO) earnings time?
Myomo Inc (MYO) earnings time is at May 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is MYO EPS forecast?
MYO EPS forecast for the fiscal quarter 2025 (Q1) is -0.08.
---